Deep Polymers Ltd Case Study Research Report

Asked by CNI Follower · 9 hrs ago · 19-08-2026

Deep Polymers Ltd – Case Study Style Research Note

(All data latest available as of 18 August 2026 unless specified)

---

1. Company Snapshot

- Business: Manufacturer of plastic masterbatches and polymer-based additives/fillers, sold to plastic processors across packaging, textiles, films, and other applications. The company has been manufacturing masterbatches since 1992 and antifab filler masterbatches since 2004. (deeppoly.com)

- Incorporation: 2005 (Deep Polymers Ltd). (screener.in)

- Listing:

- Listed on BSE SME on 23 August 2018 (ticker: 541778 – DEEP). (bseindia.com)

- Migrated to BSE Main Board w.e.f. 12 March 2021 (B Group). (bseindia.com)

- Market Cap: ~₹91.8 crore

- Share Price: ₹37.0 (BSE close on 18 August 2026)

- Valuation Snapshot: P/E 12.7x, P/B ~0.85x, ROE ~7%, ROCE ~8.7% (FY26). (screener.in)

- Registered Office & Plants: Gandhinagar district (Gujarat) plus additional facilities/associate entities in Gujarat and Uttar Pradesh with pan‑India distribution. (deeppoly.com)

---

2. Business Model & Product Profile

Core activities

- Masterbatches

- White, black, colour, UV, and a wide range of additive masterbatches (antiblock, antifog, antimicrobial, antioxidant, antistatic, flame-retardant, slip, nucleating/clarifying, optical brightener, biodegradable, PPA, etc.). (deeppoly.com)

- Antifab / Filler Masterbatches

- Calcium filler masterbatches (PP/PE; lamination & non‑lamination), super-brightener fillers, coloured tinge fillers, natural fillers, process modifiers. (deeppoly.com)

These products are blended into virgin polymers by customers to provide colour, functionality, and cost optimisation in plastic products used in: films, woven sacks, non-woven, injection/blow moulded products, pipes, fibres, and packaging.

Group/Associates

- One identified associate is Deep Additives Limited, operating in additives related to the plastics value chain. (goodreturns.in)

Strategic acquisition

- The company acquired Deep Plast for ~₹55 crore in the past, which added to its masterbatch manufacturing capacity (as per investor presentation). (stockdiscovery.s3.amazonaws.com)

---

3. Industry Context

- Deep Polymers operates in the masterbatch and specialty additives segment of the broader Indian chemicals & polymers industry.

- Key drivers:

- Growth in plastic consumption in packaging, agriculture, consumer goods, textiles, and infrastructure.

- Shift towards functional and specialty masterbatches (UV, antimicrobial, flame‑retardant, biodegradable, etc.).

- Key sensitivities:

- Volatility in crude‑linked raw material prices (polymer resins, pigments).

- Regulatory and ESG pressure on plastics, especially single‑use applications.

- The segment is fragmented, with a mix of large specialty chemical firms and numerous regional mid/small players; Deep Polymers is a small-cap, niche player.

---

4. Historical Financial Performance (Consolidated)

Revenue, profitability and margins – last 5 full years (₹ crore)

(Source: Screener consolidated P&L) (screener.in)

|-----------:|----------:|----------------:|------:|-------------:|----:|----------:|--------:|

| 2022 | 137.55 | 18.40 | 13.38 | 1.62 | 15.30 | 11.11 | 4.82 |

| 2023 | 120.46 | 15.62 | 12.97 | 2.08 | 13.48 | 9.44 | 4.10 |

| 2024 | 105.28 | 12.50 | 11.87 | 2.12 | 8.23 | 7.14 | 2.95 |

| 2025 | 98.17 | 13.60 | 13.85 | 2.76 | 7.84 | 5.20 | 2.15 |

| 2026 | 98.72 | 13.95 | 14.13 | 4.82 | 9.47 | 6.78 | 2.80 |

Key observations (case-study perspective):

1. Revenue trend

- Sharp scale-up from ~₹40 crore (FY18–21) to ₹137.6 crore in FY22, followed by three consecutive years of degrowth: 120.5 → 105.3 → 98.7 crore by FY26. (screener.in)

- The business appears to have undergone a post-expansion slowdown/normalisation, possibly due to demand cycles, competitive pricing pressure, or raw material‑driven price corrections.

2. Margins and profitability

- Operating margins improved from mid‑single digits (FY18–21) to low‑teens from FY22 onwards; FY26 OPM ~14.1%. (screener.in)

- Net profit peaked at ₹11.1 crore in FY22 and fell to ₹5.2 crore in FY25 before recovering to ₹6.8 crore in FY26. EPS followed the same pattern. (screener.in)

- FY26 also shows a larger contribution from other income (₹4.8 crore); an analyst must understand its sustainability and nature (interest income, incentives, one‑offs). (screener.in)

3. Return ratios and growth metrics

- 5‑year compounded sales growth ~20%, but 3‑year sales CAGR is negative (~‑6%), reflecting the recent slowdown.

- 5‑year compounded profit growth ~30%, but 3‑year profit CAGR around ‑10%; TTM profit growth has again turned positive (~30%). (screener.in)

- ROE ~7% and ROCE ~8.7% in FY26, below the typical 12–15% threshold that many investors consider attractive for long‑term holdings. (screener.in)

4. Quarterly pattern (recent)

- Quarterly sales over FY24–FY26 are in the ₹22–30 crore range with operating margins typically between ~11–18%.

- Net profit per quarter largely in the ₹1–3 crore band, with some volatility due to other income and taxation. (screener.in)

For a case study, the financials highlight a company that has scaled up, then faced a top‑line plateau, while maintaining reasonable but not exceptional margins.

---

5. Balance Sheet & Capital Structure

(Consolidated, key items – ₹ crore) (screener.in)

|-----------:|--------------:|---------:|----------------:|----------:|------------------:|--------------------:|-----------:|------------:|

| 2018 | 10.51 | 7.40 | 17.91 | 10.33 | 31.46 | 5.13 | 2.52 | 23.81 |

| 2022 | 23.03 | 34.80 | 57.83 | 47.25 | 115.40 | 12.81 | 20.91 | 81.68 |

| 2023 | 23.03 | 44.14 | 67.17 | 51.13 | 131.53 | 16.72 + CWIP 10.41 | 2.93 | 101.47 |

| 2024 | 24.18 | 61.10 | 85.28 | 35.72 | 133.85 | 44.13 + CWIP 1.67 | 2.95 | 85.10 |

| 2025 | 24.18 | 66.24 | 90.42 | 33.88 | 136.51 | 49.35 + CWIP 14.68 | 2.98 | 69.50 |

| 2026 | 24.18 | 80.89 | 105.07 | 30.09 | 147.45 | 58.89 + CWIP 1.67 | 10.96 | 75.93 |

Analytical points:

- Net worth has steadily increased from ~₹58 crore (FY22) to ~₹105 crore (FY26), reflecting retained earnings.

- Debt: Borrowings peaked around ₹51 crore (FY23) and declined to ~₹30 crore by FY26, indicating some deleveraging. Debt‑to‑equity is now roughly ~0.3x, moderate for a manufacturing SME. (screener.in)

- Capital intensity: Fixed assets (+ CWIP) rose sharply from ~₹12.8 crore (FY22) to ~₹60.6 crore (FY26), implying heavy capex to expand capacity and/or integration (e.g., Deep Plast acquisition, new lines). An investor must evaluate whether this capex is earning adequate returns given the subdued growth. (screener.in)

- Working capital: Working capital days and cash‑conversion cycle remain elevated (working capital days ~115–190; CCC ~150–185 days in recent years), pointing to a working‑capital heavy model with receivables and inventory intensity. (screener.in)

---

6. Shareholding Pattern & Governance

(Consolidated shareholding, % of equity) (screener.in)

|--------------|---------:|----:|------:|---------------------:|

| Mar 2022 | 62.77% | 0.00% | 37.23% | 8,409 |

| Mar 2023 | 62.80% | 0.00% | 37.20% | 9,533 |

| Mar 2024 | 64.59% | 0.03% | 35.39% | 12,849 |

| Mar 2025 | 64.61% | 0.03% | 35.36% | 10,634 |

| Mar 2026 | 65.85% | 0.03% | 34.11% | 9,757 |

| Jun 2026 | 65.89% | 0.03% | 34.09% | 9,648 |

Interpretation:

- Promoter holding is high and has inched up to around 66%, which aligns with strong control and skin in the game but also lower free float.

- Foreign institutional interest is negligible; the shareholder base is dominated by promoters and domestic public investors.

- The number of shareholders is in the 9–10k range, indicating a broad retail‑heavy base, typical of small‑cap polymer and chemicals names.

There is also a recent BSE communication (4 August 2026) where the exchange sought clarification from the company regarding significant price movement, a reminder that small‑cap stocks can show sharp volatility and attract regulatory scrutiny around disclosures. (screener.in)

---

7. Key Strategic & Corporate Developments

- Migration to Main Board (2021): Upgrading from SME to main board typically improves liquidity and institutional visibility, and often coincides with capacity or scale ambitions. (bseindia.com)

- Capacity build‑out and acquisitions: Investor presentations highlight increases in installed capacity (up to 24,000 MT in earlier years) and acquisition of Deep Plast for ₹55 crore, which materially expanded masterbatch capacity. (stockdiscovery.s3.amazonaws.com)

- Associate Deep Additives: Broadens exposure into additives; however, consolidated contribution and synergy need deeper reading of annual reports. (goodreturns.in)

- Recent financial disclosures:

- Q4 FY26 results and FY26 annual numbers show stabilising revenues and improved profitability versus FY25. (screener.in)

- Announcements indicate Q1 FY27 results (June 2026) have been approved with a qualified auditor opinion on receivables and forex restatement, which is a red flag requiring close reading of the results and notes. (screener.in)

---

8. Analytical Positives (from a case‑study lens – not a recommendation)

1. Niche, downstream chemical play

- Focused on value‑added masterbatches and antifab fillers, with an ISO‑certified process and a broad product portfolio, positioning it as a specialised supplier to plastic processors. (deeppoly.com)

2. Capacity and geographic reach

- Multiple facilities and branch network across key industrial states (Gujarat, UP, MP, Maharashtra, Delhi, West Bengal, Tamil Nadu) provide diversified demand access. (deeppoly.com)

3. Improved margins and deleveraging trend

- Operating margins improved materially from sub‑8% to low‑teens; absolute borrowings have reduced from ~₹51 crore to ~₹30 crore between FY23 and FY26. (screener.in)

4. Valuation vs book value and earnings

- As of 18 August 2026: P/B ~0.85x and P/E ~12.7x on FY26 EPS of ~₹2.8; such valuation for a small‑cap manufacturing company with positive earnings and no large legacy issues can appear “value‑oriented” in a screen, provided growth and governance risks are manageable. (screener.in)

From a study perspective, Deep Polymers illustrates a small‑cap, capital‑intensive, working‑capital‑heavy manufacturing business where the valuation looks modest largely because growth and return ratios are yet to fully justify the past capex.

---

9. Key Risks & Concerns

These are the core issues a prudent investor or analyst should focus on:

1. Growth slowdown after capex

- Despite significant capex and acquisitions, revenues have stagnated around ₹100 crore for four years (FY23–26) and are below the FY22 peak. This raises questions about capacity utilisation, demand environment, and pricing power. (screener.in)

2. Modest return ratios

- ROE ~7% and ROCE ~8–9% are moderate, especially in relation to the higher risk profile of micro‑caps and the cost of capital. Investors generally look for structurally higher returns to justify exposure. (screener.in)

3. Working capital intensity & receivables risk

- High working capital days and cash‑conversion cycle indicate funds locked up in inventory/receivables. Any slippage in collections can directly impact cash flows and debt needs. (screener.in)

- The recent qualified audit opinion related to receivables and forex restatement signalled by the Q1 FY27 result announcement is a serious risk flag and should be examined in detail. (screener.in)

4. Commodity and customer concentration risks

- Input costs are linked to crude‑derived polymers and pigments, creating margin volatility during periods of sharp raw‑material swings.

- As a B2B supplier in a fragmented market, bargaining power with large customers may be limited, affecting pricing during downcycles.

5. Small‑cap, liquidity and governance risks

- Market cap of ~₹90–100 crore and predominantly retail shareholding imply low liquidity; price can move sharply on small volumes. (screener.in)

- BSE’s recent clarification request on price movement further highlights trading‑related risk perception in the market. (screener.in)

6. No dividend track record

- Despite reporting profits, the company has not paid dividends, indicating prioritisation of reinvestment/deleveraging or limited free cash flow. (screener.in)

---

10. How to Use This Case Study (Analytical Checklist)

For academic or internal research purposes, Deep Polymers Ltd can be used to:

- Study the impact of SME listing and migration to mainboard on liquidity and valuation for a small industrial company. (bseindia.com)

- Examine how post‑capex revenue growth vs ROCE interplay affects market perception.

- Analyse financial statements to understand:

- Sustainability of other income.

- Working‑capital management and receivables quality.

- The effect of acquisitions and associates on consolidated numbers.

- Compare the company’s metrics (growth, margins, ROE, leverage) with larger masterbatch/specialty chemical peers to understand where the valuation discount/premium may be coming from. (screener.in)

For any real‑money decision, a detailed reading of the latest FY24 and FY25 annual reports, FY26 and Q1 FY27 results, and all BSE disclosures is essential. These are accessible via:

- Company’s investor relations section (Annual Reports / Financial Results / Investor Presentations). (deeppoly.com)

- BSE filing links aggregated on Screener (Announcements, Annual Reports). (screener.in)

---

Note on live data: The share price, market cap, and valuation metrics mentioned are based on publicly available data as of 18 August 2026 closing and will change with market movements. Intraday/live data is not being provided here.

If you have any further queries, please connect with us on 022-6290-10141 (Timings : 09.00 AM to 05.00 PM) or you can email us on info@cniinfoxchange.com